<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03712657</url>
  </required_header>
  <id_info>
    <org_study_id>TJH</org_study_id>
    <nct_id>NCT03712657</nct_id>
  </id_info>
  <brief_title>ERAS for Pediatric Acute Appendicitis</brief_title>
  <acronym>EPAA</acronym>
  <official_title>Multi-center Research Manual for the Perioperative Application of Enhanced Recovery After Surgery in Pediatric Acute Appendicitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter, prospective randomized controlled study is designed to applicate
      perioperative Enhanced recovery after surgery (ERAS) management for children with acute
      appendicitis, the aim is to promote postoperative recovery, shorten the hospital length of
      stay, and reduce the incidence of postoperative complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is through multi-center prospective RCT research, to discuss the
      application of ERAS in children with acute appendicitis, including its preoperative
      rehydration, postoperative analgesia, preoperative and postoperative antibiotics application,
      as well as the discharge standards and so on. The major outcome is whether it can reduce the
      length of stay in hospital (LOS), secondary outcomes are included the incidence of
      postoperative complications and postoperative readmission rate, etc.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 8, 2018</start_date>
  <completion_date type="Anticipated">October 8, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>length of stay</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
    <description>less hospital length of stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>first time for postoperative feeding</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>earlier postoperative feeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first time for postoperative exercising</measure>
    <time_frame>1-2 days</time_frame>
    <description>earlier postoperative exercising</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of postoperative complication</measure>
    <time_frame>1 months</time_frame>
    <description>less postoperative complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of re-operation</measure>
    <time_frame>1 months</time_frame>
    <description>less rate of re-operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of re-admission</measure>
    <time_frame>1 months</time_frame>
    <description>less rate of re-admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Pediatric Disorder</condition>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>ERAS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>interventions: 1.preoperative pain control; 2.avoiding application of ureter; 3.avoiding application of gastric tube; 4.avoiding application of irrigation; 5.avoiding application of drainage; 6.early exercising postoperatively; 7.early oral feeding postoperatively; 8.early discharging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conservative group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>normal treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>ERAS</intervention_name>
    <description>preoperative pain control;
avoiding application of ureter;
avoiding application of gastric tube;
avoiding application of irrigation;
avoiding application of drainage;
early exercising postoperatively;
early oral feeding postoperatively;
early discharging.</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages&lt;14; no gender limitation;

          -  Alvarado scores â‰¥7;

          -  preoperative radiography examination indicated appendicitis;

          -  Patients or their legal representatives have signed &quot;informed consent&quot;

        Exclusion Criteria:

          -  complicated life-threatening disease;

          -  perioperative exploration not appendicitis;

          -  Recently participated in other clinical trials within 3 months;

          -  Researchers found not fit to participate in this trial for any condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiexiong Feng, MD</last_name>
    <phone>0028-13986086129</phone>
    <email>fengjiexiong@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tianqi Zhu, MD</last_name>
    <phone>0028-13986295423</phone>
    <email>zhutianqi84@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>October 7, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>October 18, 2018</last_update_submitted>
  <last_update_submitted_qc>October 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ERAS</keyword>
  <keyword>Pediatric surgery</keyword>
  <keyword>Emergency</keyword>
  <keyword>Both of systolic and diastolic will be measured</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for all primary and secondary outcome measures will be made available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>data will be available within 6 months of study completion.</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by an external independent review panel. requestors will be required to sign a data access agreement.</ipd_access_criteria>
    <ipd_url>http://bethesda.org</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

